Novo Nordisk’s chunky valuation risks crash diet aimeedonnellan
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Breakingviews - Novo Nordisk’s chunky valuation risks crash dietNovo Nordisk’s weighty valuation could be headed for a crash diet. On Thursday, the maker of diabetes and obesity remedies was worth over $270 billion, twice its value only two years ago. But its untarnished bull run may be scuppered by competition from rival Eli Lilly , questions about effectiveness and market size.
Les mer »
Investors see big Novo Nordisk stock boost if obesity drug shows heart benefitPositive trial data showing Novo Nordisk’s obesity drug helps save and extend lives, not just lose weight, could propel Europe's best-performing stock even higher, according to 10 investors and industry analysts interviewed by Reuters.
Les mer »
Novo Nordisk cuts some US supply of obesity drug Wegovy to cope with demandDanish drug developer Novo Nordisk said it would have to halve the supply of starter doses of its popular Wegovy weight-loss drug in the United States to cope with high demand after reporting forecast-beating results on Thursday.
Les mer »
Wegovy Maker to Limit Starter-Dose Supplies in U.S. as Demand SurgesLower-strength starter doses of the obesity drug will be held back in the U.S. to safeguard supplies, said pharmaceutical company Novo Nordisk.
Les mer »
Is This Nearby Asteroid a Chunk of the Moon?Is asteroid Kamo?oalewa a chunk of the Moon? A new study shows that it could be, but only samples can tell us for certain.
Les mer »
Asteroid Found Orbiting Earth Might Be a Chunk of The MoonThe Moon dominates our view of the night sky.
Les mer »